Study shows age doesn't affect survival outcomes in patients with MDS who receive a HCT
Results from a prospective study of 1,280 patients with myelodysplastic syndrome (MDS) showed that survival at 100 days and at two years following hematopoietic cell transplant (HCT) for patients aged 65 and older is comparable ...
Dec 6, 2015
0
3